Skip to main content
. Author manuscript; available in PMC: 2022 May 9.
Published in final edited form as: Alzheimers Dement. 2021 Sep 5;18(5):942–954. doi: 10.1002/alz.12451

Table 1.

Patient data by study group.

Non-demented Demented (AD)
Demographic Features
Number 16 15
Age (years)
  Mean (SD) 85.3 (6.0) 85.3 (6.0)
  Median (IQR) 86.5 (81.8-89.8) 86.0 (81.0-90.0)
Sex (Male/Female) (8/8) (7/8)
Post-mortem Interval (hours)
  Mean (SD) 4.6 (1.4) 7.4 (11.1)
  Median (IQR) 4.5 (3.5-5.5) 4.3 (3.3-5.8)
Alzheimer’s Pathology
Number 16 15
Braak Stage
  B1: Braak 0-II 9 0
  B2: Braak III/IV 7 0
  B3: Braak V/VI 0 15
  Mean (SD) 2 (1) 6 (1)
  Median (IQR) 2 (2-3) 6 (5-6)
CERAD Score
  0 16 0
  3 0 15
  Mean (SD) 0 (0) 3 (0)
  Median (IQR) 0 (0-0) 3 (3-3)
Age of tissue (years)
  Mean (SD) 10.3 (4.3) 10.1 (4.0)
  Median (IQR) 9.0 (7.0-14.0) 10.0 (7.0-13.0)
Cognitive Features
MMSE Score (points)
  Number 16 13
  Mean (SD) 27.6 (2.2) 18.8 (7.4)
  Median (IQR) 28.0 (26.3-29.8) 22.0 (14.0-24.0)

Abbreviations: AD, Alzheimer’s disease; CERAD, Consortium to Establish a Registry for Alzheimer’s Disease; MMSE, Mini-Mental State Examination; IQR, interquartile range; SD, standard deviation.